Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Mar
25
2020
 Top 10 Questions Asked By Medical Group Clients In Response To COVID-19 Sheppard, Mullin, Richter & Hampton LLP
Mar
25
2020
 Legal Implications of COVID-19 for Pharmaceutical and Medical Device Companies in the United Kingdom McDermott Will & Schulte LLP
Mar
25
2020
 Stated Purpose More Decisive than Definition in Construing Claims McDermott Will & Schulte LLP
Mar
25
2020
 US EPA Revises TSCA Chemical Data Reporting Requirements and Extends Deadline for 2020 Reporting Period Squire Patton Boggs (US) LLP
Mar
25
2020
 COVID-19 Vaccine Test Lab Hit by Maze Ransomware Robinson & Cole LLP
Mar
25
2020
 DEA Releases Draft Rules Related to Cannabis Medical Research Dinsmore & Shohl LLP
Mar
25
2020
 False Advertisement and Unjust Enrichment Claims Against Kombucha Brewer Dismissed for Lack of Notice and Lack of Conferred Benefit Keller and Heckman LLP
Mar
25
2020
 USDA Extends Comment Period for Salmonella Citizen Petition Keller and Heckman LLP
Mar
25
2020
 Five Things Brand Owners Should Do Now To Guard Against Increase in Scams and Counterfeit Goods During COVID-19 Pandemic Dinsmore & Shohl LLP
Mar
25
2020
 Florida Issues New Emergency Order Further Relaxing Licensure, Telehealth, and Practice Standards to Combat COVID-19 Foley & Lardner LLP
Mar
25
2020
 Rhode Island Issues Emergency Regulations on Off-Label Prescribing for COVID-19, and Guidance on Telehealth and Reciprocal Licensure Robinson & Cole LLP
Mar
25
2020
 FDA Seeks to Improve Ventilator Access, Relaxes REMS Requirements During COVID-19 McDermott Will & Schulte LLP
Mar
25
2020
 Cannabusinesses Should Take Advantage of Their Extra Time to File Tax Returns to Ensure Proper Reductions in Their Taxable Income for Cost of Goods Sold Norris McLaughlin P.A.
Mar
24
2020
 New OIG and FBI Announcements Highlight Coronavirus Fraud Schemes Targeting Americans Jones Walker LLP
Mar
24
2020
 COVID-19 and the New Jersey Alcoholic Beverage Industry Norris McLaughlin P.A.
Mar
24
2020
 Medical Marijuana Deemed “Essential” During COVID-19 Pandemic Epstein Becker & Green, P.C.
Mar
24
2020
 Enforcers, Experts Discuss Tamping Down Anticompetitive Behavior in Bio Market During FDA/FTC Workshop MoginRubin
Mar
24
2020
 FDA Eases Device Modification Rules to Expand Availability of Ventilators During COVID-19 Pandemic Epstein Becker & Green, P.C.
Mar
24
2020
 COVID-19 – Legal Implications for Pharmaceutical and Medical Device Companies in Germany McDermott Will & Schulte LLP
Mar
24
2020
 FDA Offers Guidance on Clinical Trials During COVID-19 Pandemic McDermott Will & Schulte LLP
Mar
24
2020
 FDA Confirms That At-Home Collection Kits Are Not Authorized for Use with COVID-19 Tests Epstein Becker & Green, P.C.
Mar
24
2020
 The Global Patent Race for a COVID-19 Vaccine Summa PLLC
Mar
23
2020
 FDA’s Role in Battling the COVID-19 Pandemic: Part I What Manufacturers, Diagnostic Laboratories and Their Insurers Need to Know Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
23
2020
 TTB and FDA Relax Restrictions on the Production of Hand Sanitizers by Alcohol Manufacturers McDermott Will & Schulte LLP
Mar
23
2020
 Antitrust Enforcers Target Coronavirus-related Violations Proskauer Rose LLP
Mar
23
2020
 US EPA Issues List of Disinfectants Qualified for Use Against COVID-19 and Initiates Expedited Review Process for Approving Product Claims Against the Virus Squire Patton Boggs (US) LLP
Mar
23
2020
 Attack on PFASs Extends to Food Packaging Keller and Heckman LLP
Mar
23
2020
 U.S. DOT Issues Guidance Regarding Drug And Alcohol Testing During COVID-19 Crisis Jackson Lewis P.C.
Displaying 5797 - 5824 of 12600
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters